| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 02/03/2004 | USRE38416 Cross-linking oligonucleotides |
| 02/03/2004 | US6686471 Process and intermediates for growth hormone secretagogues |
| 02/03/2004 | US6686374 Azaindoles having serotonin receptor affinity |
| 02/03/2004 | US6686369 α-hydrdroxylic acid derivatives, their production and use |
| 02/03/2004 | US6686368 Inhibitors of factor Xa |
| 02/03/2004 | US6686366 Compounds specific to adenosine A3 receptor and uses thereof |
| 02/03/2004 | US6686359 Growth hormone secretagogues |
| 02/03/2004 | US6686358 Anticoagulants; cardoviscular disorders |
| 02/03/2004 | US6686352 Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives |
| 02/03/2004 | US6686343 Triazolopurine derivatives, pharmaceutical compositions containing the derivatives, and adenosine A3 receptor affinitive agents |
| 02/03/2004 | US6686318 Heterocyclically substituted aromatic amino compounds with a herbicidal effect |
| 02/03/2004 | CA2128876C Triazolopyrimidine derivatives as angiotensin ii receptor antagonists |
| 01/29/2004 | WO2004010512A2 Heteroatom-containing diamondoid transistors |
| 01/29/2004 | WO2004009784A2 Novel inhibitors of kinases |
| 01/29/2004 | WO2004009710A1 Polymerisable diketopyrrolopyrroles, use of such compounds in colour filters and polymers prepared from these compounds |
| 01/29/2004 | WO2004009602A1 Pyrazolopyrimidines as kinase inhibitors |
| 01/29/2004 | WO2004009601A1 Azaindole kinase inhibitors |
| 01/29/2004 | WO2004009600A1 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/29/2004 | WO2004009599A1 Five-membered heteroaromatic olefinic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of ncotinic cholinergic receptors |
| 01/29/2004 | WO2004009597A2 Pyrazolopyrimidines as protein kinase inhibitors |
| 01/29/2004 | WO2004009596A2 Pyrazolopyrimidines as kinase inhibitors |
| 01/29/2004 | WO2004009586A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 01/29/2004 | WO2004009542A2 Process for preparing certain pyrrolotriazine compounds |
| 01/29/2004 | WO2004009036A2 Compounds compositions and methods |
| 01/29/2004 | WO2004009017A2 Modulators of the glucocorticoid receptor and method |
| 01/29/2004 | WO2003053366A3 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 01/29/2004 | WO2003042172A3 C-5 modified indazolylpyrrolotriazines |
| 01/29/2004 | US20040019214 Carbocyclic carbo, oxo amines such as N-heptyl-3-methyl-4-oxo -1,4-dihydroquinoline-2-carboxamide, used for prophylaxis of gastrointerstinal disorders |
| 01/29/2004 | US20040019210 Kinase inhibitors |
| 01/29/2004 | US20040019204 Cyclization of sulfur compounds, in the presence of oxidizers, bases and coordination compounds having catalyst selectivity and stereospeficity; catalysis |
| 01/29/2004 | US20040019201 Refluxing tetracyanoethylene oxide with tetraphenylporphyrin to form (5,10,15,20-tetraphenyl-2,3-(3'-dicyano)cyclopropano -2,3-chlorin); macromolecule intermediates used as chelate compounds; photosensitivity |
| 01/29/2004 | US20040019097 Oxidizing an indole derivative in a reaction solution containing an organic solvent; electrostatic shields |
| 01/29/2004 | US20040019095 N, N'-dimethylated N-confused porphyrins |
| 01/29/2004 | US20040019063 Nitrogen compounds such as 4-(7-Hydroxy-1,3-dioxo-tetrahydro-pyrrolo(1,2-c)imidazol-2-yl)-5,6,7,8-tetrahydronaphthalene-1-carbonitrile, used for prophylaxis of muscular disorders; aging |
| 01/29/2004 | US20040019059 Drugs such as N-(4-benzoylphenyl)-4,5-dihydro-3-(3-pyridinyl)-5-isoxazolecarboxamide, used as antiinflammatory or antiarthritic agents |
| 01/29/2004 | US20040019057 Imidazo-pyrazine derivatives as ligands for gaba receptors |
| 01/29/2004 | US20040019052 5-(2,3-Difluorophenyl)-1H-pyrazolo(3,4-c)pyridazin-3-ylamine, e.g.; an enzyme inhibitor of GSK-3, a serine/threonine protein kinase; neuroprotectants in treatment of acute stroke, neurotraumatic injuries and diabetic conditions |
| 01/29/2004 | US20040019041 Method for the production of imidazo-(1,2-C)(2,3)-benzodiazepines and intermediates in the production thereof |
| 01/29/2004 | US20040019034 Pyrrolotriazolopyrimidinone derivatives |
| 01/29/2004 | US20040019031 Nitrogen-containing macrocyclic compounds modulating intra-and extracellular levels of oxidants such as superoxide radicals, hydrogen peroxide and peroxynitrite radicals |
| 01/29/2004 | US20040019019 Administering a bicyclic or tricyclic amidino derivative compounds for the treatment of diseases mediated by nitric oxide synthase |
| 01/29/2004 | DE10230605A1 Substituierte Imidazotriazine Substituted imidazotriazines |
| 01/29/2004 | DE10230604A1 Heterocyclisch substituierte Imidazotriazine Heterocyclic substituted imidazotriazines |
| 01/29/2004 | DE10229778A1 Neue Verwendung von Imidazotriazinonen New use of imidazotriazinones |
| 01/29/2004 | CA2492861A1 Process for preparing certain pyrrolotriazine compounds |
| 01/29/2004 | CA2492704A1 Heteroatom-containing diamondoid transistors |
| 01/29/2004 | CA2492665A1 Azaindole kinase inhibitors |
| 01/29/2004 | CA2491251A1 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/28/2004 | EP1384718A1 Intramolecular amidation of sulfamate esters catalyzed by metalloporphyrins |
| 01/28/2004 | EP1383771A1 9-deazaguanine derivatives as inhibitors of gsk-3 |
| 01/28/2004 | EP1383770A1 Method for the production of 4,6-diaminopyrimido 5,4-d]pyrimidines |
| 01/28/2004 | EP1383769A2 6-substituted pyrazolo 3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors |
| 01/28/2004 | EP1383768A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 01/28/2004 | EP1383747A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 01/28/2004 | EP1383743A2 Dual inhibitors of pde 7 and pde 4 |
| 01/28/2004 | EP1383741A2 Process for the preparation of benazepril |
| 01/28/2004 | EP1383515A1 Activation of natural killer cells by adenosine a3 receptor agonists |
| 01/28/2004 | EP1383506A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7 |
| 01/28/2004 | EP1383503A2 Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops |
| 01/28/2004 | EP1383498A1 Crf receptor antagonists |
| 01/28/2004 | EP1299378A4 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/28/2004 | EP1218382B1 Bicyclic imidazo-3-yl-amine derivatives |
| 01/28/2004 | EP1181335B1 Extended rhodamine compounds useful as fluorescent labels |
| 01/28/2004 | CN1471534A 桥(连)哌嗪衍生物 Bridge (even) piperazine derivatives |
| 01/28/2004 | CN1471533A N-([1,2,4] triazoloazinyl) thiophene sulfonamide compounds as herbicides |
| 01/28/2004 | CN1471532A Process for the preparation of z-alkoxy-6-trifluoromethyl-N-[(C1,2,4] triazolo[1,5-C] pyrimidin-2-yl) benzensulfonamides |
| 01/28/2004 | CN1471521A Amino alkoxybenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same |
| 01/28/2004 | CN1471511A Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 01/28/2004 | CN1471397A Method for treatment of migraine |
| 01/28/2004 | CN1136220C Process for preparing hexaaza-Zinc ore type structure paraffin derivatives |
| 01/28/2004 | CN1136219C Pyrazolopyrimidinone derivatives for the treatment of impotence |
| 01/27/2004 | US6683142 1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators |
| 01/27/2004 | US6683105 Highly selective butyrylcholinesterase inhibitors such as cymserine or others can prevent or treat cognitive impairments associated with aging or alzheimer's disease |
| 01/27/2004 | US6683091 Heterocyclic sulfanamides; alzheimer's disease; preventing deposition of amyloid protein |
| 01/27/2004 | US6683090 N-(1-azabicyclo(2.2.2)oct-3-yl)propenamide derivatives; psychotic and intellectual impairment disorders |
| 01/27/2004 | US6683081 Triazolotriazinones and the use thereof |
| 01/27/2004 | US6683080 Treatment of diabetes mellitus |
| 01/27/2004 | US6683073 Such as 7-methoxy-8-(6'-(4''-fluorophenyl)-2'-methyl-pyrimidine-4'-yloxy)alkoxy -(11as)-1,2,3,11a-tetrahydro-5h-pyrrolo(2,1,c)(1,4)benzodiazepin-5-one |
| 01/22/2004 | WO2004007948A1 Roller tappet with cold advance |
| 01/22/2004 | WO2004007604A1 High-molecular-weight polymeric material comprising diketopyrrolopyrrole pigments |
| 01/22/2004 | WO2004007510A1 Novel chemical substance having activity for morphogenesis and growth promotion |
| 01/22/2004 | WO2004007501A1 Biologically active compounds |
| 01/22/2004 | WO2004007500A1 Novel diketopyrrolopyrrole pigments |
| 01/22/2004 | WO2004007499A1 3-furanyl analogs of toxoflavine as kinase inhibitors |
| 01/22/2004 | WO2004007498A2 3-phenyl analogs of toxoflavine as kinase inhibitors |
| 01/22/2004 | WO2004007479A1 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
| 01/22/2004 | WO2004007469A1 New alkynylated quinazolin compounds as mmp-13 inhibitors |
| 01/22/2004 | WO2004007407A2 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 01/22/2004 | WO2004006846A2 Receptor-type kinase modulators and methods of use |
| 01/22/2004 | WO2004006836A2 Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds |
| 01/22/2004 | WO2003055447A3 Heterocyclic acridone inhibitors of impdh enzyme |
| 01/22/2004 | US20040014974 Formed by reduction and catalytic hydrogenation; for nuclear magnetic resonance |
| 01/22/2004 | US20040014963 Self-assembling; porphyrins; calixarenes |
| 01/22/2004 | US20040014803 Antilipemic agents; anticholesterol agents; cardiovascular disorders |
| 01/22/2004 | US20040014784 Substituted propargylamines |
| 01/22/2004 | US20040014783 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 01/22/2004 | US20040014763 beta-sheet mimetics and composition and methods relating thereto |
| 01/22/2004 | US20040014762 Pyrrolopyridazine compounds |
| 01/22/2004 | US20040014760 4- (2-butylamino) -2, 7-dimethyl-8- (2-methyl-6-methoxypyrid-3-YL) pyrazolo- [1,5-A] -1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 01/22/2004 | US20040014759 6,5-Fused bicyclic heterocycles |